EpiVax Therapeutics logo

EpiVax Therapeutics jobs and careers

Providence, RI, United States

About EpiVax Therapeutics

EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.

Founded in 2017 by Anne S. De Groot, Bill Martin and Gad Berdugo.

Founded
2017
Employees
1 to 10
Total funding
$1.5M
Headquarters
Providence

Leadership

The top of EpiVax Therapeutics's org chart, with how many people report into each leader.

AGPhoto of Annie De Groot

Annie De Groot

CEO

3 reports

GCPhoto of Gregory Covino

Gregory Covino

CFO

GSPhoto of Gary Steinberg

Gary Steinberg

Chief Medical Officer

WMPhoto of William Martin

William Martin

Co-Founder, COO & CIO

Board

MCPhoto of Manon Cox

Manon Cox

Advisor

JLPhoto of Judy Lieberman

Judy Lieberman

Advisor

DBPhoto of Dominique Bridon

Dominique Bridon

Advisor

RLPhoto of Richard Lipkin

Richard Lipkin

Director

DAPhoto of Dan Adams

Dan Adams

Chairman, Board of Directors

ARPhoto of Amy Rosenberg

Amy Rosenberg

Advisor